Inlife Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 13-12-2024
- Paid Up Capital ₹ 1.57 M
as on 13-12-2024
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.66 Cr
as on 13-12-2024
- Revenue -1.13%
(FY 2022)
- Profit -6.48%
(FY 2022)
- Ebitda 0.08%
(FY 2022)
- Net Worth 21.80%
(FY 2022)
- Total Assets 23.13%
(FY 2022)
About Inlife Pharma
The Corporate was formerly known as Orbit It Consulting Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.57 M.
The company currently has active open charges totaling ₹1.66 Cr.
Anil Kanodia, Prateek Agarwal, Chetan Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TG1999PTC032540
- Company No.
032540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Inlife Pharma Private Limited offer?
Inlife Pharma Private Limited offers a wide range of products and services, including Herbal Capsules, Guduchi Capsules, Nutraceuticals, Food Supplement, Dietary Supplements, Flaxseed Oil Capsule, Diabetic Herbal Medicine, Diabetic Herbal Tablets & Capsules, Green Tea, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Inlife Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kanodia  | Managing Director | 01-Feb-2001 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prateek Agarwal | Director | 15-Apr-2013 | Current |
| Mukta Agarwal | Director | 10-Dec-2018 | Current |
| Chetan Agarwal | Director | 15-Apr-2013 | Current |
Financial Performance and Corporate Structure Insights of Inlife Pharma.
Inlife Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.13% decrease. The company also saw a slight decrease in profitability, with a 6.48% decrease in profit. The company's net worth Soared by an impressive increase of 21.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inlife Pharma?
In 2022, Inlife Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Mar 2023 | ₹1.93 M | Open |
Hdfc Bank Limited Creation Date: 03 Jul 2021 | ₹1.68 M | Open |
Hdfc Bank Limited Creation Date: 16 Apr 2019 | ₹1.30 Cr | Open |
How Many Employees Work at Inlife Pharma?
Unlock and access historical data on people associated with Inlife Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inlife Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inlife Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
